Modulators of syndecan-2, such as an antibody to syndecan-2 that cross-links syndecan-2 on the cell surface or a syndiecan-2 polypeptide that interferes with syndecan-2 receptor binding, is used to regulate a Th17 mediated disease such as an autoimmune disease, fibrosis or cancer.
申请公布号
WO2016154019(A1)
申请公布日期
2016.09.29
申请号
WO2016US23178
申请日期
2016.03.18
申请人
ORBSEN THERAPEUTICS LIMITED;ELLIMAN, Stephen J.;BARKLEY, Laura Rose;KAVANAUGH, Jack
发明人
ELLIMAN, Stephen J.;BARKLEY, Laura Rose;KAVANAUGH, Jack
